TY - JOUR
T1 - Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital
AU - Nishida, Yoshihiro
AU - Ikuta, Kunihiro
AU - Natsume, Atsushi
AU - Ishihara, Naoko
AU - Morikawa, Maki
AU - Kidokoro, Hiroyuki
AU - Muramatsu, Yukako
AU - Nonobe, Norie
AU - Ishizuka, Kanako
AU - Takeichi, Takuya
AU - Kanbe, Miki
AU - Mizuno, Seiji
AU - Imagama, Shiro
AU - Ozaki, Norio
N1 - Funding Information:
This work was supported in part by the National Cancer Center Research and Development Fund (29-A-3) and Health and Labor Sciences Research Grant (H29-013).
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Neurofibromatosis type 1 (NF1) is a genetic multisystem disorder. Clinicians must be aware of the diverse clinical features of this disorder in order to provide optimal care for it. We have set up an NF1 in-hospital medical care network of specialists regardless of patient age, launching a multidisciplinary approach to the disease for the first time in Japan. From January 2014 to December 2020, 246 patients were enrolled in the NF1 patient list and medical records. Mean age was 26.0 years ranging from 3 months to 80 years. The number of patients was higher as age at first visit was lower. There were 107 males (41%) and 139 females. After 2011, the number of patients has increased since the year when the medical care network was started. Regarding orthopedic signs, scoliosis was present in 60 cases (26%), and bone abnormalities in the upper arm, forearm, and tibia in 8 cases (3.5%). Neurofibromas other than cutaneous neurofibromas were present in 90 cases (39%), and MPNST in 17 cases (7.4%). We launched a multidisciplinary NF1 clinic system for the first time in Japan. For patients with NF1, which is a hereditary and systemic disease associated with a high incidence of malignant tumors, it will be of great benefit when the number of such clinics in Japan and the rest of Asia is increased.
AB - Neurofibromatosis type 1 (NF1) is a genetic multisystem disorder. Clinicians must be aware of the diverse clinical features of this disorder in order to provide optimal care for it. We have set up an NF1 in-hospital medical care network of specialists regardless of patient age, launching a multidisciplinary approach to the disease for the first time in Japan. From January 2014 to December 2020, 246 patients were enrolled in the NF1 patient list and medical records. Mean age was 26.0 years ranging from 3 months to 80 years. The number of patients was higher as age at first visit was lower. There were 107 males (41%) and 139 females. After 2011, the number of patients has increased since the year when the medical care network was started. Regarding orthopedic signs, scoliosis was present in 60 cases (26%), and bone abnormalities in the upper arm, forearm, and tibia in 8 cases (3.5%). Neurofibromas other than cutaneous neurofibromas were present in 90 cases (39%), and MPNST in 17 cases (7.4%). We launched a multidisciplinary NF1 clinic system for the first time in Japan. For patients with NF1, which is a hereditary and systemic disease associated with a high incidence of malignant tumors, it will be of great benefit when the number of such clinics in Japan and the rest of Asia is increased.
UR - http://www.scopus.com/inward/record.url?scp=85107536215&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107536215&partnerID=8YFLogxK
U2 - 10.1038/s41598-021-91345-6
DO - 10.1038/s41598-021-91345-6
M3 - Article
C2 - 34099792
AN - SCOPUS:85107536215
SN - 2045-2322
VL - 11
JO - Scientific reports
JF - Scientific reports
IS - 1
M1 - 11933
ER -